Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Phase 1

• Conditions: Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

• Registration Number: NCT00531635
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA \& Mycophenolate Mofetil

Detailed Description

Not available

Study Timeline

• Study Start: 2002-07
• Study First Submitted: 2007-09-17
• Study First Submitted QC: 2007-09-17
• Study First Posted: 2007-09-19
• Status Verified: 2011-12
• Last Update Submitted: 2011-12-11
• Last Update Posted: 2011-12-13
• Primary Completion: 2012-06
• Study Completion: 2012-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

• Patients receiving Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil.

Exclusion Criteria

• Uncontrolled major medical illnesses

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Efficacy	2001-2012

Trial Locations

Locations (1)

KFSH&RC; 🇸🇦 Riyadh, Saudi Arabia